VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider ve… Read more
Market Cap & Net Worth: VVT Med Inc. (VVTM)
VVT Med Inc. (V:VVTM) has a market capitalization of $9.77 Million (CA$14.04 Million) as of March 19, 2026. Listed on the V stock exchange, this Canada-based company holds position #29078 globally and #177 in its home market, demonstrating a -22.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VVT Med Inc.'s stock price CA$0.21 by its total outstanding shares 66833600 (66.83 Million).
VVT Med Inc. Market Cap History: 2025 to 2026
VVT Med Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $13.96 Million to $9.77 Million (0.00% CAGR).
VVT Med Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VVT Med Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VVTM by Market Capitalization
Companies near VVT Med Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to VVT Med Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
VVT Med Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, VVT Med Inc.'s market cap moved from $13.96 Million to $ 9.77 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$9.77 Million | -30.00% |
| 2025 | CA$13.96 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of VVT Med Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.77 Million USD |
| MoneyControl | $9.77 Million USD |
| MarketWatch | $9.77 Million USD |
| marketcap.company | $9.77 Million USD |
| Reuters | $9.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.